Can Sigma Labs Bring 3D Printing Back to Life?
Sigma Labs may not be a household name, but that could change now that the company has announced that it had been awarded a contract by Mitsubishi Heavy Industries
All Work
Chris Lange
Are Palo Alto Networks’ Q4 Earnings Enough For Investors?
Palo Alto Networks, Inc. (NYSE: PANW | PANW Price Prediction) released fiscal fourth-quarter financial results after markets closed Monday. The firm said that it had $1.48 in earnings per share (EPS) and $950.4 million…
This Cancer Genetics Merger Could Be the Future for Biotechs
Cancer Genetics shares more than doubled on Monday after the company announced a merger with StemoniX.
Is Onconova Therapeutics in Serious Trouble After This Late-Stage Cancer Study?
Onconova Therapeutics stock was absolutely crushed to start out the week after the company reported results from its late-stage cancer study.
Best Buy, Dollar General, Palo Alto Networks, Salesforce and More Earnings Due This Week
24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports expected this week, including Best Buy, Hewlett Packard Enterprise and Salesforce.com.
Foot Locker Is One Retailer Shrugging Off COVID-19 With Q2 Results
Specialty retailer Foot Locker reported better than expected quarterly results before the markets opened on Friday and reinstated its dividend.
Why This Analyst Sees Even More Upside for Apple After the $2 Trillion Mark
Wedbush reiterated an Outperform rating and with a price target that implies upside of 11% from the most recent closing price.
The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine
Pfizer and BioNTech provided an update for their coronavirus vaccine that is currently in the late stages of development and testing.
The Secret Behind L Brands Posting a Profit in Q2
L Brands, owners of Victoria's Secret and Bath & Body Works, posted second-quarter earnings per share (EPS) of $0.25 and $2.32 billion in revenue. Analysts were expecting a net loss of $0.42 per share…
Can Hotel Reservations Outlast Waves of Hotel Bankruptcies?
COVID-19 has wreaked absolute havoc on many industries but hotels seem to be getting some of the worst of it. A new national report from Trepp, a data analytics firm, the demonstrated that the…
Johnson & Johnson’s Newest Multibillion Dollar Acquisition
After Momenta Pharmaceuticals announced that it would be acquired by pharmaceutical giant Johnson & Johnson, the biotechnology company's shares soared on Wednesday.
The FDA Comes Down on Gilead and Galapagos With CRL
The FDA has come down on an investigational treatment for moderately to severely active from Gilead Sciences and Galapagos.
What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia
BioMarin Pharmaceutical stock was crushed on Wednesday after an FDA response regarding its valoctocogene roxaparvovec gene therapy for severe hemophilia A.
6 Top Earnings Season Winners Beyond Apple and Amazon
These companies were really big winners in the most recent earnings reporting season. They have survived the pandemic and then some, and they have the fundamentals to prove it.
Why MICT Soared on Tuesday
MICT, a global fintech company, announced today that its Micronet subsidiary has received a significant order and will soon begin a trial of its SmartCam product with an unnamed partner.
Vanda Pharma’s Big Step Forward in COVID-19 Pneumonia
Vanda Pharmaceuticals took another big step forward in the fight against COVID-19 on Tuesday morning.
Kohl’s Proves Pitfalls of Being a Nonessential Business
Kohl’s shares tumbled even though it reported better than expected fiscal second-quarter financial results before the markets opened on Tuesday.
Wall Street Sees, Jamf, an Apple Enterprise Play, Headed Higher
The quiet period for software developer Jamf is over now, so a slew of analyst calls are coming in for this stock.
XBiotech Has Identified COVID-19 Antibodies to Be Used as Therapy
XBiotech shares made a handy gain on Monday after the company said that it has identified True Human antibodies that could potentially be used as a therapy against SARS-CoV2.
Unity Bio Stock Is Literally Kneecapped
Unity Biotechnology stock was absolutely crushed on Monday after the company announced results from its midstage study in patients with moderate-to-severe painful osteoarthritis of the knee.